Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Influenza01:27

Influenza

101
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
101
Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Vaccines01:21

Vaccines

104
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
104
Vaccine Production01:23

Vaccine Production

152
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
152
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Leaky Scanning02:28

Leaky Scanning

4.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recognition and Management of Infectious Biothreats and Emerging Pathogens.

Critical care clinics·2026
Same author

AI and the Future of Medical Countermeasures to Protect Against Biological Threats.

Open forum infectious diseases·2026
Same author

Immunomodulator Stockpiling as a Means of Broad Defense From Biological Threats.

Critical care explorations·2025
Same author

Introduction to the Special Feature, Part 2: Enabling and Implementing Threat Agnostic Approaches to Biodefense and Public Health.

Health security·2024
Same author

Introduction to the Special Feature: Threat Agnostic Approaches to Biodefense and Public Health Are Now a Reality.

Health security·2024
Same author

Innovative approaches to COVID-19 medical countermeasure development.

The Journal of antimicrobial chemotherapy·2023

Related Experiment Video

Updated: May 5, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K

The influenza vaccine menu.

Amesh A Adalja

    Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
    |November 22, 2013
    PubMed
    Summary

    This column explains clinical issues and their biosecurity implications for policymakers. It simplifies complex medical topics for non-medical audiences, enhancing understanding of healthcare delivery and challenges.

    Area of Science:

    • Public Health Policy
    • Biosecurity
    • Healthcare Management

    Background:

    • Policymakers require accessible information on clinical issues impacting biosecurity.
    • Existing medical literature often lacks clarity for non-medical decision-makers.
    • Effective healthcare delivery and management are crucial for national security.

    Purpose of the Study:

    • To provide concise explanations of clinical matters relevant to biosecurity.
    • To bridge the knowledge gap between medical practice and policy-making.
    • To inform decision-makers on hospital practices and healthcare challenges.

    Main Methods:

    • Articles are written for a non-medical audience.
    • Focus on current topics of interest in healthcare and biosecurity.

    More Related Videos

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
    05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    28.9K
    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    36.1K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
    08:52

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

    Published on: July 26, 2019

    8.6K
    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
    05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    28.9K
    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    36.1K
  • Explanations are brief and emphasize implications for policymakers.

    • Main Results:

    • The column simplifies complex medical issues for better understanding.
    • It highlights practical aspects of hospital operations and medical challenges.
    • Information is tailored to inform biosecurity-related policy decisions.

    Conclusions:

    • The 'Medicine for Policymakers' column serves as a vital resource for informed decision-making.
    • It enhances the understanding of clinical issues and their biosecurity relevance among policymakers.
    • Facilitates better integration of medical insights into public health and security strategies.